2302 related articles for article (PubMed ID: 19205510)
1. [Expression of activation antigens on the lymphocytes T in patients with carcinoma of the larynx and connection with tumor features].
Starska K; Głowacka E; Łukomski M; Lewy-Trenda I; Józefowicz-Korczyńska M; Durko M; Lewkowicz P
Otolaryngol Pol; 2008; 62(6):674-9. PubMed ID: 19205510
[TBL] [Abstract][Full Text] [Related]
2. [Production of cytokines by peripheral blood mononuclear cells--correlation with clinicomorphological features in laryngeal carcinoma].
Starska K; Lukomski M; Lewy-Trenda I; Stasikowska O; Józefowicz-Korczyńska M; Durko M; Głowacka E
Otolaryngol Pol; 2008; 62(4):388-94. PubMed ID: 18837209
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Foxp3 and RORgamma t in peripheral blood mononuclear cells in patients with laryngeal carcinoma as indicators of tumor stage--preliminary study].
Papież P; Bryś M; Lewy-Trenda I; Stasikowska O; Woś J; Papierz W; Starska K
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):109-16. PubMed ID: 22000260
[TBL] [Abstract][Full Text] [Related]
6. [Expression of transcription nuclear factor NFkappaB in laryngeal carcinoma tumor cells--correlation with IL-10 expression by blood mononuclear cells and clinicomorphological features].
Starska K; Stasikowska O; Lewy-Trenda I; Głowacka E; Łukomski M
Otolaryngol Pol; 2009 Sep; 63(7):28-34. PubMed ID: 20564897
[TBL] [Abstract][Full Text] [Related]
7. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.
Chadburn A; Inghirami G; Knowles DM
Hematol Pathol; 1992; 6(4):193-202. PubMed ID: 1362727
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
9. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
10. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of tumor markers in squamous cell carcinoma of the larynx.
Eleftheriadou A; Chalastras T; Ferekidou E; Kyriou L; Yiotakis I; Pappas Z; Ferekidis E; Kandiloros D
Anticancer Res; 2006; 26(3B):2493-7. PubMed ID: 16821638
[TBL] [Abstract][Full Text] [Related]
12. [Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma].
Lukomski M; Lewy-Trenda I; Stasikowska O; Durko M; Starska K
Otolaryngol Pol; 2007; 61(5):805-10. PubMed ID: 18552024
[TBL] [Abstract][Full Text] [Related]
13. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of the expression of activation markers on T-lymphocyte subpopulations in different forms of bronchial asthma].
Beda MV; Pavliuk AS; Veselova AV; Dement'eva EG; Solov'ev SS; Bart BIa; Koval'chuk LV
Ter Arkh; 1995; 67(3):26-9. PubMed ID: 7770797
[TBL] [Abstract][Full Text] [Related]
15. Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma.
Erfani N; Khademi B; Haghshenas MR; Mojtahedi Z; Khademi B; Ghaderi A
Immunol Invest; 2013; 42(2):81-90. PubMed ID: 23252863
[TBL] [Abstract][Full Text] [Related]
16. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
17. [Anneroth, Batsakis and Luna's modified classification as prognostic factor in patients with laryngeal carcinoma].
Starska K; Kulig A; Łukomski M
Otolaryngol Pol; 2003; 57(2):229-35. PubMed ID: 12894429
[TBL] [Abstract][Full Text] [Related]
18. Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.
Introcaso CE; Hess SD; Kamoun M; Ubriani R; Gelfand JM; Rook AH
J Am Acad Dermatol; 2005 Sep; 53(3):428-34. PubMed ID: 16112348
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood sCD3⁻ CD4⁺ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.
Singh A; Schabath R; Ratei R; Stroux A; Klemke CD; Nebe T; Flörcken A; van Lessen A; Anagnostopoulos I; Dörken B; Ludwig WD; Pezzutto A; Westermann J
Hematol Oncol; 2014 Mar; 32(1):16-21. PubMed ID: 23798351
[TBL] [Abstract][Full Text] [Related]
20. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
